Pfizer and GlaxoSmithKline have closed their joint venture to combine their respective consumer healthcare businesses and form the world’s largest over-the-counter business. This new venture will operate as the new GSK Consumer Healthcare.
New data from the Consumer Healthcare Products Association and IRI is highlighting the ripple effect that a consumer buying an OTC product can have on the American healthcare system — namely, some $146 billion in savings.
Alongside it shedding its pharmaceutical business, Perrigo said it had entered an exclusive agreement with a subsidiary of Kenilworth, N.J.-based Merck to develop an over-the-counter formulation of Merck’s Nasonex nasal spray
LONDON — If Pfizer follows through with its announcement last week to potentially place its consumer business up for sale, GlaxoSmithKline, presently the third-largest OTC seller in the U.S. marketplace, would certainly take a look at it, the company's CEO shared Wednesday morning.